Skip to content

ABUS

Arbutus Biopharma Corp

NASDAQ · Healthcare · Biotechnology · US

$4.21
−1.64%
Ask drillr

Leverage

Debt / equity
0.01x
Net debt / equity
-0.06x
Debt / assets
0.01x
Debt / EBITDA
0.02x
Net debt / EBITDA
-0.10x

Liquidity & coverage

Current ratio
81.42x
Quick ratio
81.42x
Cash ratio
27.53x
Interest coverage
—
EBITDA / interest
—
Working capital
$270.5M

Cash & dividend

FCF / debt
-6.79x
Cash flow / debt
-6.79x
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026